UK markets close in 5 hours 48 minutes

Bone Biologics Corporation (BBLG)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.5400+0.0500 (+3.36%)
At close: 04:00PM EDT
1.4900 -0.05 (-3.25%)
After hours: 04:38PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 13.87M
Enterprise value 26.63M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.30
Enterprise value/revenue N/A
Enterprise value/EBITDA -20.82

Trading information

Stock price history

Beta (5Y monthly) 0.35
52-week change 3-69.74%
S&P500 52-week change 3-5.62%
52-week high 37.1220
52-week low 31.0800
50-day moving average 31.3579
200-day moving average 32.4806

Share statistics

Avg vol (3-month) 320.02k
Avg vol (10-day) 349.24k
Shares outstanding 510.35M
Implied shares outstanding 6N/A
Float 83.15M
% held by insiders 169.61%
% held by institutions 10.62%
Shares short (14 Jul 2022) 419.22k
Short ratio (14 Jul 2022) 40.9
Short % of float (14 Jul 2022) 40.61%
Short % of shares outstanding (14 Jul 2022) 40.19%
Shares short (prior month 14 Jun 2022) 424.21k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 323 Jul 2018
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-31.98%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
Net income avi to common (ttm)-1.87M
Diluted EPS (ttm)-0.1810
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.81M
Total cash per share (mrq)0.56
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)110.97
Book value per share (mrq)0.58

Cash flow statement

Operating cash flow (ttm)-1.96M
Levered free cash flow (ttm)-3.47M